Biologics company gets $500K for meniscus repair product

Biologics

Ortho Regenerative Technologies received a $500,000 grant from Axelys to develop its Ortho-M meniscus repair product.

The grant will accelerate development of the product's second clinical indication, according to a May 26 news release. Ortho Regenerative Technologies is behind orthobiologic products including Ortho-R. 

Axelys is a nonprofit organization supporting public research and innovation.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers